探索治疗进展:对肠道微生物群调节者的全面审查
Lara Pires1,2,3, Ana M González-Paramás3, Sandrina A Heleno1,2
1Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.
Antibiotics (Basel, Switzerland)
|August 29, 2024
概括
肠道微生物群影响健康,失衡 (失生症) 与疾病有关. 本综述探讨了益生菌和益生菌等疗法,以恢复微生物平衡和治疗相关疾病.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 肠道微生物群,一个复杂的微生物生态系统,在宿主新陈代谢和从出生起的免疫力中起着至关重要的作用.
- 肠道微生物失调,这种生态系统的不平衡,与各种疾病有关,包括胃肠道,心血管和自身免疫疾病.
- 遗传学,饮食和药物等因素可以显著影响肠道微生物群的组成和功能.
研究的目的:
- 综合审查目前旨在调节肠道微生物组的治疗策略.
- 根据最新的科学文献,评估各种微生物群调节者的有效性和局限性.
- 为医疗从业者提供有关影响力微生物组改变疗法的最新信息,以治疗与失生症相关的疾病.
主要方法:
- 对肠道微生物群调节的最新科学研究进行系统审查.
- 对治疗方法的分析,包括益生菌,益生菌,共生菌,后生菌和微生物衍生产品.
- 评估研究结果,以评估每个治疗策略的有效性和局限性.
主要成果:
- 失生症通过促进有害细菌和炎症导致疾病.
- 多种治疗干预措施,包括益生菌,益生菌和共生菌,显示出恢复肠道微生物平衡的潜力.
- 最近的研究强调了这些基于微生物群的疗法在管理与失生症相关的健康问题方面的承诺.
结论:
- 基于微生物群的疗法为治疗与肠道失调相关的疾病提供了一个有希望的途径.
- 需要进一步的研究,以充分阐明这些干预措施的有效性和最佳应用.
- 了解微生物群调节的进展对于临床实践至关重要.
更多相关视频
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
122
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
122
Drugs for Treatment of Diarrhea-Predominant IBS
153
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
153
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
328
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
328
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
111
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
111
Bacterial Flora of the Large Intestine
400
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
400
Drugs for Treatment of Constipation-Predominant IBS
146
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
146


